Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis.
Healthcare-acquired infections
Hospital-acquired sepsis
ICU-acquired sepsis
Incidence
Sepsis
Journal
Intensive care medicine
ISSN: 1432-1238
Titre abrégé: Intensive Care Med
Pays: United States
ID NLM: 7704851
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
28
02
2020
accepted:
11
05
2020
pubmed:
28
6
2020
medline:
28
4
2021
entrez:
28
6
2020
Statut:
ppublish
Résumé
Sepsis is recognized as a global public health problem, but the proportion due to hospital-acquired infections remains unclear. We aimed to summarize the epidemiological evidence related to the burden of hospital-acquired (HA) and ICU-acquired (ICU-A) sepsis. We searched MEDLINE, Embase and the Global Index Medicus from 01/2000 to 03/2018. We included studies conducted hospital-wide or in intensive care units (ICUs), including neonatal units (NICUs), with data on the incidence/prevalence of HA and ICU-A sepsis and the proportion of community and hospital/ICU origin. We did random-effects meta-analyses to obtain pooled estimates; inter-study heterogeneity and risk of bias were assessed. Of the 13,239 studies identified, 51 met the inclusion criteria; 22 were from low- and middle-income countries. Twenty-eight studies were conducted in ICUs, 13 in NICUs, and ten hospital-wide. The proportion of HA sepsis among all hospital-treated sepsis cases was 23.6% (95% CI 17-31.8%, range 16-36.4%). In the ICU, 24.4% (95% CI 16.7-34.2%, range 10.3-42.5%) of cases of sepsis with organ dysfunction were acquired during ICU stay and 48.7% (95% CI 38.3-59.3%, range 18.7-69.4%) had a hospital origin. The pooled hospital incidence of HA sepsis with organ dysfunction per 1000 patients was 9.3 (95% CI 7.3-11.9, range 2-20.6)). In the ICU, the pooled incidence of HA sepsis with organ dysfunction per 1000 patients was 56.5 (95% CI 35-90.2, range 9.2-254.4) and it was particularly high in NICUs. Mortality of ICU patients with HA sepsis with organ dysfunction was 52.3% (95% CI 43.4-61.1%, range 30.1-64.6%). There was a significant inter-study heterogeneity. Risk of bias was low to moderate in ICU-based studies and moderate to high in hospital-wide and NICU studies. HA sepsis is of major public health importance, and the burden is particularly high in ICUs. There is an urgent need to improve the implementation of global and local infection prevention and management strategies to reduce its high burden among hospitalized patients.
Identifiants
pubmed: 32591853
doi: 10.1007/s00134-020-06106-2
pii: 10.1007/s00134-020-06106-2
pmc: PMC7381455
doi:
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1536-1551Références
Crit Care Med. 2009 Jan;37(1):81-8
pubmed: 19050636
PLoS One. 2014 Sep 16;9(9):e107181
pubmed: 25226033
Lancet Infect Dis. 2012 Dec;12(12):919-24
pubmed: 23103175
JAMA. 2017 Oct 3;318(13):1241-1249
pubmed: 28903154
Crit Care Med. 2018 Apr;46(4):494-499
pubmed: 29303796
Lancet Infect Dis. 2018 May;18(5):e159-e171
pubmed: 29100898
Crit Care Med. 2017 Jul;45(7):1168-1176
pubmed: 28422777
Int J Infect Dis. 2015 Aug;37:80-5
pubmed: 26051976
Croat Med J. 2006 Jun;47(3):404-9
pubmed: 16758518
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Crit Care Med. 2007 Nov;35(11):2538-46
pubmed: 17828034
Ann Ig. 2018 Sep-Oct;30(5 Supple 2):15-21
pubmed: 30374508
Rev Bras Epidemiol. 2013 Mar;16(1):77-86
pubmed: 23681325
Intensive Care Med. 2016 Dec;42(12):1980-1989
pubmed: 27686355
J Hosp Infect. 2010 Oct;76(2):156-60
pubmed: 20579770
BMC Infect Dis. 2015 Mar 25;15:152
pubmed: 25885702
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Crit Care Med. 2001 Jul;29(7):1303-10
pubmed: 11445675
Scand J Infect Dis. 2003;35(9):677-82
pubmed: 14620154
Antimicrob Resist Infect Control. 2017 Jan 10;6:6
pubmed: 28078082
Euro Surveill. 2018 May;23(18):
pubmed: 29741152
Am J Infect Control. 2015 Jan;43(1):86-8
pubmed: 25564130
Environ Health Prev Med. 2006 Nov;11(6):298-303
pubmed: 21432359
N Engl J Med. 2017 Aug 3;377(5):414-417
pubmed: 28658587
Crit Care Med. 2003 Apr;31(4):1250-6
pubmed: 12682500
Intensive Care Med. 2018 Apr;44(4):499-501
pubmed: 29500700
Indian J Pediatr. 2010 Jan;77(1):37-9
pubmed: 20135266
Intensive Care Med. 2007 Mar;33(3):435-43
pubmed: 17225161
J Clin Epidemiol. 2012 Sep;65(9):934-9
pubmed: 22742910
Am J Infect Control. 1988 Jun;16(3):128-40
pubmed: 2841893
Lancet Respir Med. 2018 Mar;6(3):223-230
pubmed: 29508706
Dtsch Med Wochenschr. 2013 Aug;138(34-35):1717-22
pubmed: 23934590
Minerva Anestesiol. 2013 Sep;79(9):993-1002
pubmed: 23811620
Crit Care. 2008;12(6):R158
pubmed: 19091069
Pediatr Infect Dis J. 2014 Feb;33(2):152-7
pubmed: 24413407
J Chemother. 2008 Feb;20(1):134-6
pubmed: 18343757
Antimicrob Resist Infect Control. 2019 Jul 15;8:114
pubmed: 31338161
Infection. 2012 Aug;40(4):415-23
pubmed: 22371234
Crit Care. 2008;12(5):R121
pubmed: 18801161
Infection. 2005 Jun;33(3):122-8
pubmed: 15940412
Am J Infect Control. 2016 Nov 1;44(11):e235-e241
pubmed: 27317408
Lancet Infect Dis. 2019 Jan;19(1):4-6
pubmed: 30409682
Chest. 1992 Jun;101(6):1644-55
pubmed: 1303622
J Infect Prev. 2018 May;19(3):104-106
pubmed: 29796091
BMJ. 2012 Nov 14;345:e7401
pubmed: 23152569
Rev Med Chil. 2007 May;135(5):620-30
pubmed: 17657331
Turk J Pediatr. 2010 Sep-Oct;52(5):464-70
pubmed: 21434530
N Engl J Med. 2003 Apr 17;348(16):1546-54
pubmed: 12700374
Pediatr Crit Care Med. 2005 Jan;6(1):2-8
pubmed: 15636651
Crit Care Med. 2006 Jun;34(6):1589-96
pubmed: 16625125
Lancet. 2011 Jan 15;377(9761):228-41
pubmed: 21146207
Clin Microbiol Infect. 2019 Apr;25(4):462-468
pubmed: 30036671
Lancet. 2020 Jan 18;395(10219):200-211
pubmed: 31954465
Braz J Infect Dis. 2008 Feb;12(1):75-9
pubmed: 18553019
Infect Control Hosp Epidemiol. 2018 Nov;39(11):1277-1295
pubmed: 30234463
Crit Care Med. 2008 Apr;36(4):1105-13
pubmed: 18379234
Crit Care Med. 2007 May;35(5):1284-9
pubmed: 17414725
Euro Surveill. 2018 Nov;23(46):
pubmed: 30458912
Intensive Care Med. 2012 Jul;38(7):1191-7
pubmed: 22527068
Crit Care Med. 2018 Jun;46(6):926-934
pubmed: 29533311
Crit Care Med. 2006 Oct;34(10):2576-82
pubmed: 16915108
Lancet Respir Med. 2014 May;2(5):380-6
pubmed: 24740011
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
BMC Med Res Methodol. 2016 Oct 12;16(1):137
pubmed: 27733132
J Crit Care. 2005 Mar;20(1):46-58
pubmed: 16015516
Intensive Care Med Exp. 2019 Sep 27;7(Suppl 3):55
pubmed: 31559498
JAMA Pediatr. 2018 Apr 1;172(4):312-314
pubmed: 29459982
Acta Anaesthesiol Scand. 2011 Jul;55(6):722-31
pubmed: 21480832
J Med Assoc Thai. 2009 Mar;92 Suppl 2:S68-78
pubmed: 19562989
Anaesthesiol Intensive Ther. 2015;47(1):7-13
pubmed: 25751289
Crit Care Med. 2015 Sep;43(9):1945-51
pubmed: 26110490
Lancet Infect Dis. 2017 Nov;17(11):1180-1189
pubmed: 28826588
Biomedica. 2014 Jan-Mar;34(1):40-7
pubmed: 24967858
Am J Respir Crit Care Med. 2016 Feb 1;193(3):259-72
pubmed: 26414292
Open Forum Infect Dis. 2018 Nov 19;5(12):ofy313
pubmed: 30555852
J Infect Public Health. 2015 Sep-Oct;8(5):418-24
pubmed: 25952595
Crit Care Med. 2011 Jul;39(7):1675-82
pubmed: 21685740
Med Care. 2016 Mar;54(3):303-10
pubmed: 26759980
Am J Infect Control. 2007 Apr;35(3):190-5
pubmed: 17433943
Enferm Infecc Microbiol Clin. 2006 May;24(5):307-12
pubmed: 16762256
PLoS Med. 2016 Oct 18;13(10):e1002150
pubmed: 27755545
N Engl J Med. 2018 Nov 1;379(18):1732-1744
pubmed: 30380384